Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment
NCT04363216
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
66
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Ascorbic Acid
Sponsor
Thomas Jefferson University